MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12937-025-01214-5

Медицинская библиотека · Nutrition journal · 2025

Clinical randomized trial of vitamin D and C supplementation in critically ill patients with respiratory failure.

Velayati Aynaz, Vafa Mohammadreza, Yadollahzadeh Mahdi, Shariat Panahi Zahra Vahdat, Sarbakhsh Parvin, Salemi Hamidreza

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Acute respiratory failure (ARF) is the most common organ failure, affecting up to 30% of all intensive care unit (ICU) admissions. Since vitamin deficiencies are frequent in critically ill patients, and considering that the two primary mechanisms involved in ARF are inflammation and oxidative stress, this study aims to investigate the effects of co-supplementation of vitamins D and C on inflammatory parameters, oxidative stress, and clinical outcomes in critically ill ARF patients.

METHODS

In this double-blind, randomized, placebo-controlled trial, ARF patients admitted to the ICU were randomly assigned to either the intervention group (daily 2000 mg of intravenous vitamin C plus 5000 IU of oral vitamin D) or the control group (placebo). The intervention lasted 10 days, and patients were followed for 90 days, assessing inflammation, oxidative stress parameters, and clinical outcomes.

RESULTS

Thirty-four patients in the intervention group and 33 in the control group completed the trial. At the end of the intervention, High-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and malondialdehyde (MDA) were significantly reduced, while total antioxidant capacity (TAC) increased significantly in the intervention group compared to both the baseline and the control group (p < 0.001). Among the clinical outcomes, only the duration of ICU stay was shorter in the intervention group (0.028). However, 90-day survival (HR 0.55; 95% CI 0.21–1.41; P = 0.22) did not show a significant difference between the two groups.

CONCLUSIONS

Our study concluded that vitamin D and C supplementation may improve inflammation and oxidative status in critically ill ARF patients, reducing ICU stays but not affecting 90-day mortality. TRIAL REGISTRATION: The study has been registered at https://irct.behdasht.gov.ir/ . Number: IRCT20090822002365N29.Registered on 2023-08-05 and it was ethically approved by the Committee of Iran University of Medical Sciences (registration IR.IUMS.REC.1402.210).

Для цитирования: Velayati Aynaz, Vafa Mohammadreza, Yadollahzadeh Mahdi, Shariat Panahi Zahra Vahdat, Sarbakhsh Parvin, Salemi Hamidreza. Clinical randomized trial of vitamin D and C supplementation in critically ill patients with respiratory failure.. Nutrition journal. 2025. DOI: 10.1186/s12937-025-01214-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.